About Avata Biosciences
Avata Biosciences is a company based in New York (United States) founded in 2023. It operates as a B2B, and Research and Development. Avata Biosciences offers products and services including AVAT-021 Capsule, AVAT-022 Aqueous Solution, AVAT-031 Solid Dose, and AVAT-041 Solid Dose. Avata Biosciences operates in a competitive market with competitors including Skye Bioscience, GW Pharma, IGC Pharma, MIRA Pharmaceuticals and NEUROPATHIX, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Avata Biosciences
Avata Biosciences offers a comprehensive portfolio of products and services, including AVAT-021 Capsule, AVAT-022 Aqueous Solution, AVAT-031 Solid Dose, and AVAT-041 Solid Dose. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Capsule formulation for treating adult focal epilepsy.
Water-soluble solution for neurological disease management.
Solid dose preparation for pediatric focal epilepsy.
Solid dose for schizophrenia and opioid sparing.
Funding Insights of Avata Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Avata Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Avata Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Avata Biosciences Comparisons
Competitors of Avata Biosciences
Avata Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Skye Bioscience, GW Pharma, IGC Pharma, MIRA Pharmaceuticals and NEUROPATHIX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cannabinoid-based therapies for glaucoma and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of cannabinoid medicines for MS spasticity, cancer pain and childhood epilepsy
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products targeting neurological disorders like Alzheimer's are developed.
|
|
| domain | founded_year | HQ Location |
Cannabinoid-based therapeutics for chronic pain and anxiety are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics targeting inflammation, neurodegeneration, oxidative stress, and neuropathic pain
|
|
| domain | founded_year | HQ Location |
Cannabis-based therapeutics are developed for pain and neurological disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Avata Biosciences
When was Avata Biosciences founded?
Avata Biosciences was founded in 2023.
Where is Avata Biosciences located?
Avata Biosciences is headquartered in New York, United States. It is registered at New York, New York, United States.
What does Avata Biosciences do?
Avata Biosciences is a clinical-stage pharmaceutical company that combines synthetic cannabinoids with a novel formulation process to create medicines for neurological conditions. It focuses on improving bioavailability and scalability in manufacturing, targeting underserved patient populations. The company partners with institutions like Oxford University for research in mental health. Based in locations including the United States and United Kingdom, it advances programs through preclinical and clinical stages for diseases such as epilepsy and schizophrenia.
Who are the top competitors of Avata Biosciences?
Avata Biosciences's top competitors include IGC Pharma, MIRA Pharmaceuticals and GW Pharma.
What products or services does Avata Biosciences offer?
Avata Biosciences offers AVAT-021 Capsule, AVAT-022 Aqueous Solution, AVAT-031 Solid Dose, and AVAT-041 Solid Dose.